Imerys (NK) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
H1 2025 sales were stable on a comparable basis (organic growth -0.4%), with persistent low industrial activity in Europe and a weaker North American economy; Q2 2025 revenue declined 10.7% year-over-year, mainly due to soft volumes and US dollar depreciation, partially offset by positive pricing.
Adjusted EBITDA for H1 2025 was €281 million (16% of sales), up 1.7% like-for-like and excluding joint ventures, supported by price increases, cost savings, and strong conductive additives business.
The Emili lithium project advanced, with a pre-feasibility study confirming strong fundamentals, a 373 Mt resource at 1.0% Li₂O, a 50-year mine life, and revised construction costs; commercial production is now planned for 2030.
Net income, Group share, for H1 2025 was €70 million, down over 50% year-over-year, reflecting lower current net income and reduced joint venture contributions.
Investments in growth areas like conductive additives and innovation are delivering significant sales and profit contributions.
Financial highlights
H1 2025 revenue: €1,757 million, down 8.4% reported, flat organic growth (-0.4%) as price increases offset lower volumes.
Adjusted EBITDA for H1 2025: €281 million (16% margin), up 1.7% like-for-like; Q2 margin reached 17.3%.
Net current free operating cash flow for H1 2025: €40 million, down from €88 million in H1 2024, mainly due to lower profitability and reduced dividends from JVs.
Net financial debt as of June 30, 2025: €1,410 million, up €135 million from December 2024, mainly due to dividend payments; net financial debt/adjusted EBITDA: 2.5x.
Investment grade ratings confirmed by S&P (BBB-, stable) and Moody's (Baa3, stable); high liquidity with €1,010 million in credit lines and €464 million in cash.
Outlook and guidance
Full-year 2025 adjusted EBITDA targeted at €540–580 million, assuming no material deterioration in the macroeconomic environment.
Volumes expected to turn positive in H2 2025, driven by tariff agreements, innovation, and a rebound in construction and EV markets.
Management remains confident in navigating ongoing geopolitical and macroeconomic uncertainties.
Latest events from Imerys
- Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Strong 2024 results, higher dividend, strategic progress, and all resolutions approved.NK
AGM 20253 Feb 2026 - H1 2024 adjusted EBITDA rose 11% to €384m, margin 20%, with strong cash flow and guidance.NK
H1 20242 Feb 2026 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 202417 Jan 2026 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 202524 Dec 2025 - Organic growth, margin expansion, and strong ESG progress with robust 2025 outlook.NK
H2 202415 Dec 2025 - Revenue down 0.7% YTD; cost controls and strategic growth moves support profitability.NK
Q3 20251 Nov 2025